Kidney disease is a common, irreversible complication of diabetes. Researchers have developed an algorithm that uses genetic markers to predict whether a type 2 diabetic will develop kidney disease ...
Please provide your email address to receive an email when new articles are posted on . Researchers evaluated four increasingly stringent eGFR-based algorithms for patients with CKD. The results could ...
Roche and KlinRisk have secured CE mark approval for their AI-driven risk stratification tool, designed for evaluating the progression of kidney function decline. The new tool, a part of Roche's newly ...
Please provide your email address to receive an email when new articles are posted on . Hospitalization rates at 1 year were 20.7% in the intervention group and 21.1% for usual care. Risk of ED visits ...
2022 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily-- New research on Cancer is the subject of a report. According to news reporting originating from ...
Roche Holdings AG received CE-mark for the Kidney Klinrisk algorithm, an AI-based tool developed in collaboration with Klinrisk Inc. to stratify risk and assess the progressive decline in kidney ...
Unrecognized disease progression is associated with higher health care costs both for patients with end-stage kidney disease and late-stage (stages G4-G5) chronic kidney disease. Objectives: Many ...
A major international analysis has found that finerenone offers better survival and stronger heart–kidney protection than spironolactone for people living with chronic kidney disease (CKD) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback